ASPN
Aspen Aerogels, Inc.
ASPN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
ASPN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Strong |
ASPN's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASPN PE Valuation
ASPN has no meaningful PE right now: it lost money over the past year.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
ASPN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect ASPN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ASPN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.57 | +$2.14 |
| Q2 2026 | -$1.52 | +$2.28 |
| Q1 2026 | -$1.35 | +$2.13 |
| Q4 2025 | -$4.73 | -2882% |
| Q3 2025 | -$3.71 | -37200% |
| Q2 2025 | -$3.80 | -$3.79 |
| Q1 2025 | -$3.48 | -$3.04 |
| Q4 2024 | $0.17 | +$0.83 |
ASPN has the stronger earnings trend. Trailing diluted EPS is down 142% for ASPN versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
ASPN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $85.2M | +17% |
| Q2 2026 | $49.8M | -36% |
| Q1 2026 | $37.9M | -52% |
| Q4 2025 | $41.3M | -66% |
| Q3 2025 | $73M | -38% |
| Q2 2025 | $78M | -34% |
| Q1 2025 | $78.7M | -17% |
| Q4 2024 | $123.1M | +46% |
ASPN's revenue is recovering but still below its 2024 peak: $85M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.4% | -3.8 points |
| Q2 2026 | -58% | -51 points |
| Q1 2026 | -55% | +325 points |
| Q4 2025 | -170% | -182 points |
| Q3 2025 | -4.6% | -19 points |
| Q2 2025 | -6.6% | -24 points |
| Q1 2025 | -380% | -383 points |
| Q4 2024 | 12% | +10 points |
ASPN has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over ASPN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
ASPN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.5M | -243% |
| Q2 2026 | -$18M | -$1.2M |
| Q1 2026 | $32.8M | +$40.1M |
| Q4 2025 | $13.7M | -35% |
| Q3 2025 | $5.9M | +$6M |
| Q2 2025 | -$16.8M | +$1.2M |
| Q1 2025 | -$7.4M | +$36.2M |
| Q4 2024 | $20.9M | +$51.5M |
ASPN has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
ASPN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +178K shares |
| 1 year | +0.8% | +670K shares |
| 3 years | +20% | +13.8M shares |
| 5 years | +191% | +54.6M shares |
| Available history | +245% | +59M shares |
ASPN has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
ASPN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
ASPN has more cash than debt.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASPN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 33.1 | Neutral |
ASPN's weekly RSI is 58 (neutral) and its Stochastic is 33 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ASPN PE vs Industrials Sector
| Metric | ASPN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ASPN has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
ASPN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 11% above |
| 20 week MA | $5.28 | 13% above |
| 50 week MA | $4.53 | 32% above |
| 100 week MA | $5.97 | 0.3% above |
| 200 week MA | $10.3 | 42% below |
ASPN has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
ASPN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.74 | $17.7 | +129% |
| 2021 | $17.7 | $50.8 | +187% |
| 2022 | $50.8 | $11.6 | -77% |
| 2023 | $11.6 | $15.8 | +36% |
| 2024 | $15.8 | $12.5 | -21% |
| 2025 | $12.5 | $2.94 | -76% |
| 2026 YTD | $2.94 | $5.99 | +104% |
ASPN has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.